Medicines Company (MDCO) Key Ratios

Profile for Medicines Company  (MDCO) 
$ 20.75   -0.24 (-1.14%) Volume: 613.4 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 20.75 0.00 (0.00%) Volume: 345  4:50 PM EST Feb 10, 2012
Income Statements
Revenue (LTM) ($): 472.18 m
Revenue per Share (LTM) ($): 8.71
Revenue per Employee (LTM) ($): 1,124,238.12
Revenue Growth 3 Yr: 10.42%
Revenue Growth 5 Yr: 18.26%
 
Dividends & Splits
Annual Dividend Rate ($): N/A
Annual Dividend Yield: N/A
Dividend Growth 3 Yr: N/A
Dividend Growth 5 Yr: N/A
Ex-Dividend Date: N/A
Payment Type: N/A
Financial Strength (LTM)
Quick Ratio: 3.00
Current Ratio: 3.30
Long Term Debt to Total Capital: N/A
Total Debt to Equity: N/A
Interest Coverage: N/A
Leverage Ratio: 1.30
 
Profitability (LTM)
Gross Margin: 70.40%
EBIT Margin: 15.50%
EBITDA Margin: 13.20%
Pre-Tax Profit Margin: 1.80%
Profit Margin (Cont. Op): 35.30%
Profit Margin (Total Op): 35.30%
Management Effectiveness LTM 5 Yr Avg
Return on Equity 35.00% 4.50%
Return on Capital 4.50% 4.50%
Return on Assets 3.40% 3.40%
 
Assets
Asset Turnover: 0.90
Inventory Turnover: 4.70
Receivable Turnover: 8.70
Valuation Measures
P/E Ratio: 6.70
P/E High - Last 5 Years: N/A
P/E Avg. High - Last 5 Years: N/A
P/E Low - Last 5 Years: N/A
P/E Avg. Low - Last 5 Years: N/A
 
Price to Sales: 2.41
Price to Book: 2.36
Price to Tangible Book: 2.99
Price to Cash Flow: 6.40
Price to Free Cash: 14.30